Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
28.6M
-
Shares change
-
-1.07M
-
Total reported value, excl. options
-
$312M
-
Value change
-
-$24.4M
-
Put/Call ratio
-
0.51
-
Number of buys
-
54
-
Number of sells
-
-65
-
Price
-
$10.91
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q4 2016
154 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q4 2016.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.6M shares
of 79.2M outstanding shares and own 36.13% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.56M shares), VANGUARD GROUP INC (1.92M shares), BlackRock Fund Advisors (1.57M shares), MILLENNIUM MANAGEMENT LLC (1.54M shares), D. E. Shaw & Co., Inc. (1.5M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.37M shares), RTW INVESTMENTS, LP (997K shares), BlackRock Institutional Trust Company, N.A. (983K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (786K shares), and BOGLE INVESTMENT MANAGEMENT L P /DE/ (756K shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.